Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat
- PMID: 6196645
- DOI: 10.1007/BF00497019
Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat
Abstract
Using crude synaptosomal fractions (P2 fractions) and 125I-Bolton and Hunter substance P (125I-BHSP) as a ligand, the characteristics of specific binding sites were examined in various brain structures and in the spinal cord (dorsal and ventral parts) of the rat. Scatchard plots revealed the occurrence of a single class of binding sites in the various structures studied with comparable Kd values (from 0.46 to 1.10 nmol/l in the brain and 0.51, 0.56 nmol/l in the spinal cord dorsal and ventral parts respectively) and of marked differences in the number of binding sites (Bmax) (septum greater than striatum greater than hippocampus, hypothalamus greater than mesencephalon greater than cerebral cortex and dorsal part of the spinal cord greater than ventral part). In the brain no correlation was found between the number of 125I-BHSP binding sites and the amount of substance P levels (substance P-like immunoreactivity) in synaptosomes, particularly in the hippocampus and the substantia nigra since the former structure was characterized by its low substance P content and its high number of binding sites and the reverse was observed in the substantia nigra. The ability of several C- and N-terminal fragments of substance P and of tachykinins to compete with 125I-BHSP binding to synaptosomes from the hippocampus, the hypothalamus and the dorsal part of the spinal cord was then determined. Results obtained were closely similar from one structure to another and comparable to those previously reported using whole brain synaptosomes.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.Neuroscience. 1986 Aug;18(4):857-75. doi: 10.1016/0306-4522(86)90105-3. Neuroscience. 1986. PMID: 2429231
-
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.Mol Pharmacol. 1984 Sep;26(2):248-54. Mol Pharmacol. 1984. PMID: 6207421
-
Marked regional heterogeneity of 125I-Bolton Hunter substance P binding and substance P-induced activation of phospholipase C in astrocyte cultures from the embryonic or newborn rat.J Neurochem. 1990 Feb;54(2):669-75. doi: 10.1111/j.1471-4159.1990.tb01923.x. J Neurochem. 1990. PMID: 1688922
-
Comparison of [125I]-bolton-hunter substance P binding in young and aged rat spinal cord.Brain Res. 1998 Mar 9;786(1-2):263-6. doi: 10.1016/s0006-8993(97)01463-7. Brain Res. 1998. PMID: 9555050
-
A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system.Peptides. 1984 Nov-Dec;5(6):1097-128. doi: 10.1016/0196-9781(84)90177-3. Peptides. 1984. PMID: 6085163 Review.
Cited by
-
The postsynaptic targets of substance P-immunoreactive terminals in the rat neostriatum with particular reference to identified spiny striatonigral neurons.Exp Brain Res. 1988;70(2):361-77. doi: 10.1007/BF00248361. Exp Brain Res. 1988. PMID: 2454839
-
Substance P receptors in primary cultures of cortical astrocytes from the mouse.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9216-20. doi: 10.1073/pnas.83.23.9216. Proc Natl Acad Sci U S A. 1986. PMID: 2431412 Free PMC article.
-
Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):83-6. doi: 10.1007/BF00518784. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6206401